Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BAX 855
Also known as: BAX-855
print preview
bookmark
share with colleague
General Information
Company
Baxter International Inc.
Description
Pegylated form of recombinant Factor VIII
Molecular Target
Factor VIII
Mechanism of Action
Latest Stage of Development
Phase II/III
Indication
Hemophilia
Partner
Nektar Therapeutics
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy